Claus Garbe

Claus Garbe

UNVERIFIED PROFILE

Are you Claus Garbe?   Register this Author

Register author
Claus Garbe

Claus Garbe

Publications by authors named "Claus Garbe"

Are you Claus Garbe?   Register this Author

100Publications

7094Reads

24Profile Views

Harmonisation of Outcome Parameters and Evaluation (HOPE) for actinic keratosis: protocol for the development of a core outcome set.

Trials 2019 Oct 11;20(1):589. Epub 2019 Oct 11.

Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13063-019-3696-6DOI Listing
October 2019

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

N Engl J Med 2019 08 4;381(7):626-636. Epub 2019 Jun 4.

From Institut Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif (C.R.), Aix-Marseille University, Marseille (J.J.G.), and Assistance Publique-Hôpitaux de Paris Dermatology and Clinical Investigation Center, Unité 976, Université de Paris, Hôpital Saint-Louis, Paris (C.L.) - all in France; Moscow City Oncology Hospital, Moscow (D. Stroyakovskiy), and the Petrov Research Institute of Oncology, St. Petersburg (E.L.) - both in Russia; Przychodnia Lekarska Komed, Konin (B.K.), the University of Medical Sciences, Poznań (A.M.), and the Maria Skłodowska-Curie Institute-Oncology Center, Warsaw (P.R.) - all in Poland; the University Hospital Schleswig-Holstein, Kiel (A.H.), the Department of Dermatology, University of Tübingen, Tübingen (C.G.), University Hospital Essen, Essen (D. Schadendorf), and the German Cancer Consortium, Heidelberg (D. Schadendorf) - all in Germany; the Veneto Institute of Oncology, Padua (V.C.S.), and Papa Giovanni XXIII Hospital, Bergamo (M.M.) - both in Italy; the Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Sheba Medical Center, Tel Hashomer (J.S.), and Sackler Medical School, Tel Aviv University, Tel Aviv (J.S.) - both in Israel; Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine (I.B.); Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens (H.G.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); Mount Vernon Cancer Centre, Northwood, United Kingdom (P.D.N.); the University of California, Los Angeles, Los Angeles (A.R.); the University of Texas M.D. Anderson Cancer Center, Houston (M.A.D.); Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (K.T.F.); Novartis Pharma, Basel, Switzerland (P.B.); Novartis Pharmaceuticals, East Hanover, NJ (M.T., E.G., M.V.); and the Melanoma Institute Australia, the University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1904059DOI Listing
August 2019

Diagnostic Performance of a Support Vector Machine for Dermatofluoroscopic Melanoma Recognition: The Results of the Retrospective Clinical Study on 214 Pigmented Skin Lesions.

Diagnostics (Basel) 2019 Aug 25;9(3). Epub 2019 Aug 25.

Department of Dermatology University Medical Center, 72074 Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/diagnostics9030103DOI Listing
August 2019

Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?

Neuroradiology 2019 Jul 18;61(7):775-782. Epub 2019 Apr 18.

Diagnostic and Interventional Neuroradiology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00234-019-02215-y
Publisher Site
http://dx.doi.org/10.1007/s00234-019-02215-yDOI Listing
July 2019

Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.

Eur J Cancer 2019 Jul 15;116:207-215. Epub 2019 Jun 15.

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.05.015DOI Listing
July 2019

S1 guidelines for dermatofibrosarcoma protuberans (DFSP) - update 2018.

J Dtsch Dermatol Ges 2019 Jun 22;17(6):663-668. Epub 2019 May 22.

Department of Dermatology, Venereology and Allergology, University Medical Center, Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13849DOI Listing
June 2019

S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018.

J Dtsch Dermatol Ges 2019 Jun;17(6):663-668

Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Mainz.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13849_gDOI Listing
June 2019

Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma Registry.

J Am Acad Dermatol 2019 May 29;80(5):1299-1307.e7. Epub 2019 Jan 29.

Center for Dermatooncology, Department of Dermatology, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.01.044DOI Listing
May 2019

Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control Study.

Acta Derm Venereol 2019 Apr;99(4):404-411

Department of Clinical Epidemiology and Applied Biostatistics, University Hospital Tübingen, DE-72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-3107DOI Listing
April 2019

BRAF mutation testing in melanoma: results from a German observational multicenter study.

Virchows Arch 2019 Jan 7;474(1):71-78. Epub 2018 Nov 7.

Division of Dermato-Oncology, University-Department of Dermatology, Liebermeisterstr. 25, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00428-018-2480-4
Publisher Site
http://dx.doi.org/10.1007/s00428-018-2480-4DOI Listing
January 2019

Lack of survival benefit in sentinel lymph node-positive melanoma with immediate complete lymphadenectomy - a review.

J Dtsch Dermatol Ges 2019 Jan 3;17(1):7-13. Epub 2018 Dec 3.

Centre for Dermato-oncology, University Department of Dermatology, Eberhard Karls University, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13707DOI Listing
January 2019

Kein Überlebensvorteil beim Sentinel-Lymphknoten-positiven Melanom mit sofortiger kompletter Lymphadenektomie - eine Übersicht.

J Dtsch Dermatol Ges 2019 Jan;17(1):7-14

Zentrum für Dermatoonkologie, Universitäts-Hautklinik, Eberhard Karls Universität, Tübingen.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13707_gDOI Listing
January 2019

Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy.

Cancer Immunol Immunother 2018 Dec 14;67(12):1845-1851. Epub 2018 Sep 14.

Department of Dermatology, University Medical Center Tübingen, Liebermeisterstraße 25, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-018-2244-7
Publisher Site
http://dx.doi.org/10.1007/s00262-018-2244-7DOI Listing
December 2018

Vemurafenib.

Recent Results Cancer Res 2018;211:77-89

Division of Dermatooncology, Department of Dermatology, University Medical Centre, Liebermeisterstr. 25, 72074, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-91442-8_6DOI Listing
November 2018

S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies.

Br J Cancer 2018 08 28;119(3):339-346. Epub 2018 Jun 28.

Department of Dermatology, University Hospital Tuebingen, Liebermeisterstrasse 25, 72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0167-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070917PMC
August 2018

Patient acceptance and trust in automated computer-assisted diagnosis of melanoma with dermatofluoroscopy.

J Dtsch Dermatol Ges 2018 Jul 21;16(7):854-859. Epub 2018 Jun 21.

Department of Dermatology, University Medical Center, Ruprecht Karl University, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ddg.13562
Publisher Site
http://dx.doi.org/10.1111/ddg.13562DOI Listing
July 2018

Patientenakzeptanz und -vertrauen in die automatisierte, computergestützte Diagnostik des Melanoms mithilfe der Dermatofluoroskopie.

J Dtsch Dermatol Ges 2018 Jul;16(7):854-860

Department of Dermatology, University Medical Center, Ruprecht Karls University Heidelberg, Germany (Hautklinik, Universitätsklinikum Heidelberg, Ruprecht-Karls-Universität Heidelberg, Deutschland).

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ddg.13562_g
Publisher Site
http://dx.doi.org/10.1111/ddg.13562_gDOI Listing
July 2018

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.

J Clin Oncol 2018 06 5;36(17):1658-1667. Epub 2017 Oct 5.

Jason Chesney, J. Graham Brown Cancer Center, University of Louisville, Louisville, KY; Igor Puzanov, Roswell Park Cancer Institute, Buffalo; Philip Friedlander, Mt Sinai School of Medicine, New York, NY; Frances Collichio, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Parminder Singh, Mayo Clinic, Phoenix, AZ; Mohammed M. Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; John Glaspy, University of California Los Angeles School of Medicine; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Lisa Chen, Jenny J. Kim, and Jennifer Gansert, Amgen, Thousand Oaks, CA; Merrick Ross, MD Anderson Cancer Center, Houston, TX; Claus Garbe, University Hospital Tuebingen, Tuebingen; Axel Hauschild, University of Kiel, Kiel, Germany; Theodore F. Logan, Indiana University Simon Cancer Center, Indianapolis, IN; Celeste Lebbé, Assistance Publique-Hôpital De Paris Dermatology and CIC Hôpital Saint Louis University Paris Diderot Sorbonne, Institut National de la Santé et de la Recherche Médicale U976, Paris, France; Robert H.I. Andtbacka, University of Utah, Salt Lake City, UT; and Howard L. Kaufman, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.7379
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.7379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075852PMC
June 2018

Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cells.

Biol Open 2018 Jun 7;7(6). Epub 2018 Jun 7.

Section of Dermato-Oncology, Department of Dermatology, Tuebingen University Hospital, Liebermeisterstrasse 25, 72076 Tuebingen, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/bio.032656DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031345PMC
June 2018

Intraprocedural 3D perfusion measurement during chemoembolisation with doxorubicin-eluting beads in liver metastases of malignant melanoma.

Eur Radiol 2018 Apr 9;28(4):1456-1464. Epub 2017 Nov 9.

Clinic für Dermato-Oncology, Eberhard-Karls University, Liebermeisterstraße 25, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-017-5099-yDOI Listing
April 2018

The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.

Eur J Cancer 2018 03 6;91:1-10. Epub 2018 Jan 6.

Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef Strauß Allee 11, 93053 Regensburg, Germany; Fraunhofer Institute of Toxicology and Experimental Medicine Regensburg ITEM-R, Division Personalized Tumour Therapy, Am Biopark 9, Regensburg, 93053, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.002DOI Listing
March 2018

How to use neoadjuvant medical treatment to maximize surgery in melanoma.

Expert Rev Anticancer Ther 2018 02 3;18(2):121-130. Epub 2018 Jan 3.

a Center for Dermatooncology, Department of Dermatology , University Hospital Tübingen , Tübingen , Germany.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1421460DOI Listing
February 2018

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.

Mol Cancer 2018 02 17;17(1):59. Epub 2018 Feb 17.

Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, University of Tübingen, Liebermeisterstr.25, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-018-0773-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816360PMC
February 2018

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start.

Eur J Nucl Med Mol Imaging 2018 Jan 22;45(1):95-101. Epub 2017 Aug 22.

Diagnostic and Interventional Radiology, Department of Radiology, Eberhard Karls University, Hoppe-Seyler-Strasse 3, 72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3813-2DOI Listing
January 2018

Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy.

J Natl Cancer Inst 2018 01;110(1)

European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; The Christie NHS Foundation Trust, Manchester, UK; University of Pittsburgh Cancer Institute and School of Medicine, Pittsburgh, PA; Mayo Clinic Rochester, Rochester, MN; University of Tubingen, Tubingen, Germany; University of Edinburgh, Western General Hospital, Edinburgh, UK; Bristol-Myers Squibb, Wallingford, CT; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK; Universitas Brawijaya, Malang, Indonesia; IDDI, Louvain-la-Neuve, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx133DOI Listing
January 2018

Safety of shortened infusion times for combined ipilimumab and nivolumab.

Cancer Immunol Immunother 2018 01 7;67(1):135-140. Epub 2017 Oct 7.

Department of Dermatology, Center for Dermatooncology, Eberhard-Karls-University of Tuebingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-017-2075-yDOI Listing
January 2018

Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry.

J Invest Dermatol 2017 12 21;137(12):2570-2577. Epub 2017 Jul 21.

Center for Dermatooncology, Department of Dermatology, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany; Central Malignant Melanoma Registry, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.07.006DOI Listing
December 2017

Immunotherapy in managing metastatic melanoma: which treatment when?

Expert Opin Biol Ther 2017 12 17;17(12):1523-1538. Epub 2017 Sep 17.

a Center for Dermatooncology, Department of Dermatology , University Hospital Tuebingen , Tuebingen , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2017.1378640DOI Listing
December 2017

Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.

Rev Endocr Metab Disord 2017 12;18(4):517-532

Center for Dermatooncology, Department of Dermatology, University Hospital Tuebingen, Liebermeisterstr. 25, 72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11154-017-9433-0DOI Listing
December 2017

'Corrigendum to "Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins" [Eur J Cancer 81 (August 2017) 203-205]'.

Eur J Cancer 2017 12 3;87:221. Epub 2017 Oct 3.

Center for Dermatooncology, Department of Dermatology, Liebermeisterstr. 25, University Hospital Tuebingen, 72076, Tuebingen, Germany; Portuguese Air Force Health Direction, Paço Do Lumiar, 1649-020 Lisbon, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.09.012DOI Listing
December 2017

Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study.

J Invest Dermatol 2017 11 21;137(11):2309-2315. Epub 2017 Jul 21.

Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.06.025DOI Listing
November 2017

Reply to 'Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma'.

Expert Opin Pharmacother 2017 10 18;18(14):1537. Epub 2017 Aug 18.

a Center for Dermatooncology, Department of Dermatology , University Hospital Tübingen , Tübingen , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1367596DOI Listing
October 2017

Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany.

J Invest Dermatol 2017 09 6;137(9):1860-1867. Epub 2017 May 6.

Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.04.020DOI Listing
September 2017

Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis.

Eur J Cancer 2017 09 7;82:171-183. Epub 2017 Jul 7.

Cancer Research UK Clinical Trials Unit, College of Medical and Dental Sciences, Robert Aitken Institute, University of Birmingham, Birmingham, B15 2TT, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.06.006DOI Listing
September 2017

Pembrolizumab-induced hepatitis: diagnosis and treatment.

J Dtsch Dermatol Ges 2017 Sep;15(9):933-935

Department of Dermatology, University Medical Center Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13037DOI Listing
September 2017

Durch Pembrolizumab verursachte Hepatitis: Diagnose und Behandlung.

J Dtsch Dermatol Ges 2017 Sep;15(9):933-935

Hautklinik, Universitätsklinikum Tübingen, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13037_gDOI Listing
September 2017

The need for psycho-oncological support for melanoma patients: Central role of patients' self-evaluation.

Medicine (Baltimore) 2017 Sep;96(37):e7987

aDepartment of Psychosomatic Medicine and Psychotherapy, University Hospital, Tuebingen bDepartment of Psychosomatic Medicine and Psychotherapy, LVR-University-Hospital, University Duisburg-Essen, Essen cDepartment of Dermatology, University Hospital, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000007987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604647PMC
September 2017

Impact of F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysis.

Eur J Nucl Med Mol Imaging 2017 Aug 18;44(8):1312-1318. Epub 2017 Mar 18.

Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tuebingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3674-8DOI Listing
August 2017

Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins.

Eur J Cancer 2017 08 20;81:203-205. Epub 2017 Jun 20.

Center for Dermatooncology, Department of Dermatology, Liebermeisterstr. 25, University Hospital Tuebingen, 72076 Tuebingen, Germany; Portuguese Air Force Health Direction, Paço Do Lumiar, 1649-020 Lisbon, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.05.018DOI Listing
August 2017

Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1.

Exp Dermatol 2017 07;26(7):598-606

Department of Dermatology, Division of Dermatooncology, University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/exd.13372DOI Listing
July 2017

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.

Eur J Cancer 2017 07 11;79:176-184. Epub 2017 May 11.

Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.04.007DOI Listing
July 2017

Imaging characteristics of cardiac metastases in patients with malignant melanoma.

Cancer Imaging 2017 Jul 1;17(1):19. Epub 2017 Jul 1.

Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Straße 3, 72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40644-017-0122-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493885PMC
July 2017

Non-melanoma skin cancer: new and future synthetic drug treatments.

Expert Opin Pharmacother 2017 May 17;18(7):689-699. Epub 2017 Apr 17.

a Center for Dermatooncology, Department of Dermatology , University Hospital Tübingen , Tübingen , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1316372DOI Listing
May 2017

Prognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up.

J Cancer Res Clin Oncol 2017 Apr 19;143(4):703-708. Epub 2016 Dec 19.

Department of Dermatology, University-Hospital-Tübingen, Eberhard-Karls-University, Liebermeisterstrasse 25, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-016-2323-0DOI Listing
April 2017

Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR).

J Cancer Res Clin Oncol 2017 Mar 22;143(3):533-540. Epub 2016 Nov 22.

Department of Dermatology, University Medical Center Tübingen, Liebermeisterstr. 25, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-016-2309-y
Publisher Site
http://dx.doi.org/10.1007/s00432-016-2309-yDOI Listing
March 2017

MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibition.

Eur J Cancer 2017 03 3;73:93-101. Epub 2017 Feb 3.

Center for Dermatooncology, Department of Dermatology, Liebermeisterstr. 25, University Hospital Tübingen, 72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.12.012DOI Listing
March 2017

The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibition.

Eur J Cancer 2017 03 3;73:85-92. Epub 2017 Feb 3.

Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Liebermeisterstr. 25, 72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.12.010DOI Listing
March 2017

Acquired resistance mechanisms to immunotherapy.

Ann Transl Med 2016 Dec;4(24):547

Center for Dermatooncology, Department of Dermatology, Liebermeisterstrasse 25, University Hospital Tübingen, 72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2016.12.21DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233497PMC
December 2016

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy.

Medicine (Baltimore) 2016 Nov;95(46):e5375

aDepartment of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel bInstitute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg, Hamburg cDepartment of Dermatology, Eberhard-Karls University of Tuebingen, Tuebingen dSkin Cancer Center Hannover, Hannover eUniversity of Hamburg, Hamburg fDepartment of Dermatology, University Hospital Erlangen, Erlangen gTABEA Clinic, Hamburg hDepartment of Dermatology, University Hospital Essen, Essen iDepartment of Dermatology, University of Mainz, Mainz jMSD Sharp & Dohme GmbH, Munich kDepartment of Dermatology, University Hospital (UKSH), Campus Lübeck, Luebeck lSkin Cancer Unit, German Cancer Research Center (DKFZ) mDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000005375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120927PMC
November 2016